Last reviewed · How we verify
Cyclotron-produced 99mTc
At a glance
| Generic name | Cyclotron-produced 99mTc |
|---|---|
| Sponsor | British Columbia Cancer Agency |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients (NA)
- An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT) (PHASE2)
- To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cyclotron-produced 99mTc CI brief — competitive landscape report
- Cyclotron-produced 99mTc updates RSS · CI watch RSS
- British Columbia Cancer Agency portfolio CI